Prenetics Global (PRE)
(Delayed Data from NSDQ)
$4.24 USD
-0.12 (-2.75%)
Updated Sep 23, 2024 03:51 PM ET
After-Market: $4.37 +0.13 (3.07%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.24 USD
-0.12 (-2.75%)
Updated Sep 23, 2024 03:51 PM ET
After-Market: $4.37 +0.13 (3.07%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Zacks News
Prenetics Global Limited (PRE) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Prenetics Global Limited (PRE). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Wall Street Analysts See Prenetics Global Limited (PRE) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Prenetics Global Limited (PRE) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Prenetics Global Limited (PRE) Stock Moves -1.14%: What You Should Know
by Zacks Equity Research
In the latest trading session, Prenetics Global Limited (PRE) closed at $0.87, marking a -1.14% move from the previous day.
Should You Invest in Prenetics Global Limited (PRE) Based on Bullish Wall Street Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Prenetics Global Limited (PRE) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Prenetics Global Limited (PRE) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Prenetics Global Limited (PRE) closed at $0.93 in the latest trading session, marking a +1.98% move from the prior day.
Prenetics Global Limited (PRE) Flat As Market Gains: What You Should Know
by Zacks Equity Research
Prenetics Global Limited (PRE) closed the most recent trading day at $0.89, making no change from the previous trading session.
Prenetics Global Limited (PRE) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Prenetics Global Limited (PRE) closed at $0.85 in the latest trading session, marking a +0.01% move from the prior day.
Wall Street Analysts Look Bullish on Prenetics Global Limited (PRE): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Prenetics Global Limited (PRE) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Prenetics Global Limited (PRE) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Prenetics Global Limited (PRE) closed at $0.79 in the latest trading session, marking a -1.89% move from the prior day.
Prenetics Global Limited (PRE) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Prenetics Global Limited (PRE) closed at $0.82 in the latest trading session, marking a +0.91% move from the prior day.
Prenetics Global Limited (PRE) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Prenetics Global Limited (PRE) closed at $0.83 in the latest trading session, marking a -0.59% move from the prior day.
4 Medical Stocks to Buy as Rate Hike Cycle Nears End
by Indrajit Bandyopadhyay
We have narrowed our search to four U.S.-based medical stocks with attractive valuations. These are HROW, LSTA, OCUP and PRE.
Prenetics Global Limited (PRE) Loses -24.21% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Prenetics Global Limited (PRE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
3 P&C Insurers to Protect Your Portfolio This Earnings Season
by Zacks Equity Research
The final quarter of 2014 escaped the miseries of huge catastrophe losses.